Trials / Completed
CompletedNCT02369159
Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza
A Phase 3, Randomized, Open Label, Active-controlled Study to Evaluate the Safety, Pharmacokinetics and Effectiveness of IV Peramivir Compared to Oral Oseltamivir in Pediatric Subjects With Acute Uncomplicated Influenza
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 137 (actual)
- Sponsor
- BioCryst Pharmaceuticals · Industry
- Sex
- All
- Age
- 0 Days – 17 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety, pharmacokinetics and effectiveness of a single dose of IV peramivir compared to a standard 5 day course of oral oseltamivir in the treatment of pediatric subjects with acute uncomplicated influenza.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Peramivir | |
| DRUG | Oseltamivir |
Timeline
- Start date
- 2015-03-11
- Primary completion
- 2019-10-28
- Completion
- 2020-05-14
- First posted
- 2015-02-23
- Last updated
- 2021-03-23
- Results posted
- 2021-03-23
Locations
10 sites across 2 countries: United States, South Africa
Source: ClinicalTrials.gov record NCT02369159. Inclusion in this directory is not an endorsement.